Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2022

View Archived Issues

Novel Fanconi anemia xenograft murine model to test immunotherapy

Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease

Autoantibody-induced murine dry eye disease model mimics human disease

Novel Nr1h3-/- mouse model exhibits AMD-like pathology

MFAP4 as a novel target in choroidal neovascularization

Across body parts, "parts list" gives insights into the lives of a cell

Chinese investigators patent new HIF inhibitors

Medivir and Rheos Medicines divulge new MALT1 inhibitors

U.S. researchers describe new PROTACs for cancer

Johns Hopkins University synthesizes MAP3K12/13 inhibitors

Chinese researchers disclose new CDK9 inhibitors

Kymera presents preclinical data on STAT3 degrader KTX-115

VERVE-101 shows durable editing of PCSK9 gene; GalNAc-LNPs improve delivery of base editors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...